Fluorescence of sanguinarine: fundamental characteristics and analysis of interconversion between various forms
- 22 July 2009
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 395 (1) , 235-240
Abstract
The quaternary isoquinoline alkaloid, sanguinarine (SG) plays an important role in both traditional and modern medicine, exhibiting a wide range of biological activities. Under physiological conditions, there is an equilibrium between the quaternary cation (SG+) and a pseudobase (SGOH) forms of SG. In the gastrointestinal tract, SG is converted to dihydrosanguinarine (DHSG). All forms exhibit bright fluorescence. However, their spectra overlap, which limited the use of powerful techniques based on fluorescence spectroscopy/microscopy. Our experiments using a combination of steady-state and time-resolved techniques enabled the separation of individual components. The results revealed that (a) the equilibrium constant between SG+ and SGOH is pK a = 8.06, while fluorescence of DHSG exhibited no changes in the pH range 5–12, (b) the SGOH has excitation/emission spectra with maxima at 327/418 nm and excited-state lifetime 3.2 ns, the spectra of the SG+ have maxima at 475/590 nm and excited-state lifetime 2.4 ns. The DHSG spectra have maxima at 327/446 nm and 2-exponential decay with components 4.2 and 2.0 ns, (c) NADH is able to convert SG to DHSG, while there is no apparent interaction between NADH and DHSG. These techniques are applicable for monitoring the SG to DHSG conversion in hepatocytes.Keywords
This publication has 20 references indexed in Scilit:
- Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosisArchives of Biochemistry and Biophysics, 2008
- Disposition of sanguinarine in the ratXenobiotica, 2007
- Metabolism of Sanguinarine: The Facts and The MythsCurrent Drug Metabolism, 2007
- DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidineBioorganic & Medicinal Chemistry, 2006
- A liquid chromatographic–mass spectrometric evidence of dihydrosanguinarine as a first metabolite of sanguinarine transformation in ratJournal of Chromatography B, 2006
- Study of the inhibition of α-amylase by the benzo[c]phenanthridine alkaloids sanguinarine and chelerythrineJournal of Enzyme Inhibition and Medicinal Chemistry, 2005
- Involvement of cytochrome P450 1A in sanguinarine detoxicationToxicology Letters, 2004
- Sanguinarine is a potent inhibitor of oxidative burst in DMSO-differentiated HL-60 cells by a non-redox mechanismChemico-Biological Interactions, 2004
- Electrophoretic investigation of interactions of sanguinarine and chelerythrine with molecules containing mercapto groupJournal of Chromatography B, 2003
- High performance liquid chromatography and capillary electrophoresis determination of sanguinarine in biological matricesJournal of Separation Science, 2003